buymodafinilrxs[.]org
“Buy Modafinil Online in Europe - AfinilEU Pharmacy & Lowest Prices”
buymodafinilrxs.org — No verificado. Resumen de las pruebas: VirusTotal 10/91 (alphaMountain.ai, Bfore.Ai PreCrime, BitDefender, Chong Lua Dao, CRDF); PhishDestroy score 88/100. Registrador: Fewmoretaps OU d/b/a T….
El análisis detallado de PhishDestroy AI se mantiene en inglés para conservar el registro forense original.
The domain buymodafinilrxs.org was registered on April 21, 2026 and is currently classified as a high‑risk generic_phishing site. The domain remains active as of the report date (July 12, 2026) and is hosted on a cloud infrastructure that suggests rapid deployment capability. Infrastructure analysis reveals that the domain resolves to the IPv4 address 3.71.180.249, which is located in Germany and belongs to an Amazon Web Services EC2 instance in the eu‑central‑1 region. The authoritative name servers are zeus.trustname.com and ares.trustname.com, both associated with the registrar Fewmoretaps OU d/b/a Trustname.com. The site presents a valid Let's Encrypt certificate (R12) and responded with an HTTP 301 redirect, indicating an intent to forward traffic to a potentially malicious landing page. Gridinsoft assigned a trust score of 0 out of 100, reflecting a lack of confidence in the host's legitimacy. Detection telemetry shows that two of ninety‑five security vendors on VirusTotal flagged the domain, and it appears on a single external blocklist that is actively used by PhishDestroy. The page title observed on the site is “Buy Modafinil Online in Europe – AfinilEU Pharmacy & Lowest Prices,” which aligns with the generic_phishing classification. No additional public intelligence, such as content screenshots or user reports, has been released, leaving the exact payload or credential‑harvesting mechanisms unverified. Defenders should add buymodafinilrxs.org to DNS and proxy blocklists, monitor outbound connections to the resolved IP address, and enforce TLS inspection to detect any subsequent redirects. Continuous re‑evaluation of the domain is advised, as threat actors may alter the hosting provider or certificate while retaining the same registration details. Organizations handling pharmaceutical‑related communications should be especially vigilant given the domain’s targeting language.
Inteligencia de seguridad de red Registrar context
Proceso de respuesta ante amenazas Pipeline
Estado de la lista de bloqueados pública
Inteligencia de dominios
Detalles técnicosDNS, SAN de SSL, marcas de tiempo
ICANN OVERSIGHT
Acreditación y contexto RAA
Acreditación y contexto RAA
Registrar accreditation and DNS abuse obligations
For this gTLD, the registrar above operates under an ICANN accreditation agreement. The links below provide the official fee schedule and current DNS abuse compliance guidance.
Accreditation is a contract, not a safety certification.
RAA §3.18 establishes abuse-contact and handling requirements. This report can document stored outbound notices and later technical observations; it does not by itself establish receipt, investigation, remediation, or contractual non-compliance.
Análisis de VirusTotal
Datos y informes externos
¿Te ha afectado esta página web?
Si ingresó credenciales de cuenta, información personal o de pago, o descargó un archivo de este dominio, tome medidas inmediatas. A continuación encontrará recursos que le ayudarán a informar el incidente y protegerse.
Informa a las autoridades locales
Seleccione su país para obtener contactos oficiales de cibercrimen o crear un borrador de queja →.
Comprobar cualquier dominio
Análisis de amenazas utilizando listas de bloqueo almacenadas, WHOIS, DNS y evidencia de escaneo público
Escanear ahoraDenunciar un intento de phishing
Envía los dominios sospechosos a nuestra base de datos de amenazas: protege a la comunidad
DenunciarFlujo de amenazas en tiempo real
Informes de phishing recientes y cambios de disponibilidad observados
MonitorizarMantente informado, mantente a salvo
Supervisa las amenazas en tiempo real o impugna esta entrada si crees que se trata de un falso positivo.